| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1972) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | C05AA06 |
| UNII: | SV0CSG527L |
| InChI Key | FAOZLTXFLGPHNG-KNAQIMQKSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H29FO4 |
| Molecular Weight | 376.47 |
| AlogP | 2.92 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 74.6 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 27.0 |
| Primary Target | |
|---|---|
| Glucocorticoid receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group I
Nuclear hormone receptor subfamily 1 group I member 2
|
1300-12600 | - | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 106 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Dry Eye Syndromes | 3 | D015352 | ClinicalTrials |
| Corneal Opacity | 2 | D003318 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 426-13-1 |
| ChEBI | 31625 |
| ChEMBL | CHEMBL1200600 |
| DrugBank | DB00324 |
| DrugCentral | 1208 |
| EPA CompTox | DTXSID7047435 |
| FDA SRS | SV0CSG527L |
| Human Metabolome Database | HMDB0014469 |
| Guide to Pharmacology | 7079 |
| PharmGKB | PA164781355 |
| PubChem | 9878 |
| SureChEMBL | SCHEMBL5051 |
| ZINC | ZINC000118912517 |